Chris Boshoff

Active 1995–2021

83
Papers
27,360
Citations
78
h-index
83
i10-index

Citations

Citations per year for Chris Boshoff1995: 4 citations1996: 29 citations1997: 103 citations1998: 148 citations1999: 230 citations2000: 226 citations2001: 295 citations2002: 250 citations2003: 277 citations2004: 211 citations2005: 152 citations2006: 200 citations2007: 177 citations2008: 156 citations2009: 115 citations2010: 219 citations2011: 160 citations2012: 148 citations2013: 165 citations2014: 196 citations2015: 182 citations2016: 203 citations2017: 198 citations2018: 150 citations2019: 660 citations2020: 734 citations2021: 777 citations2022: 621 citations2023: 468 citations2024: 758 citations2025: 296 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,962 citing papers, 29.6% of this breakdownChina: 1,864 citing papers, 18.6% of this breakdownUnited Kingdom: 674 citing papers, 6.7% of this breakdownItaly: 390 citing papers, 3.9% of this breakdownGermany: 385 citing papers, 3.9% of this breakdownFrance: 342 citing papers, 3.4% of this breakdownJapan: 280 citing papers, 2.8% of this breakdownCanada: 262 citing papers, 2.6% of this breakdownSpain: 220 citing papers, 2.2% of this breakdownAustralia: 186 citing papers, 1.9% of this breakdownSwitzerland: 178 citing papers, 1.8% of this breakdownNetherlands: 178 citing papers, 1.8% of this breakdown
0%29.6%Other 20.8%

Fields

  • Medicine58%
  • Biochemistry, Genetics and Molecular Biology33.9%
  • Immunology and Microbiology4%
  • Engineering0.8%
  • Computer Science0.7%
  • Agricultural and Biological Sciences0.4%
  • Other2.2%

Topics

  • Viral-associated cancers and disorders6.5%
  • Cytomegalovirus and herpesvirus research3.7%
  • Lung Cancer Treatments and Mutations3.6%
  • Cancer Genomics and Diagnostics3.4%
  • Cancer Immunotherapy and Biomarkers2.9%
  • RNA modifications and cancer2.5%
  • Other77.4%

Coauthors

All papers

Open in search
  1. The biology and management of non-small cell lung cancer

    Authors: , , - Nature 2018 cited by 5,055

  2. Toward personalized treatment approaches for non-small-cell lung cancer

    Authors: , , - Nature Medicine 2021 cited by 1,140

  3. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky - Nature Biotechnology 2013 cited by 2,191

  4. Kaposi's sarcoma and its associated herpesvirus

    Authors: , , - Nature reviews. Cancer 2010 cited by 877

  5. Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer Treatment

    Authors: , , , - Clinical Cancer Research 2015 cited by 401

  6. Kidney cancer: The next decade

    Authors: , , - The Journal of Experimental Medicine 2018 cited by 237

  7. APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development

    Authors: , , , , - Cell Reports 2014 cited by 355

  8. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

    Authors: , , , , , , , - The Journal of Pathology 2006 cited by 589

  9. Recurrent PTPRB and PLCG1 mutations in angiosarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sahil Seth, Xingzhi Song, Jiabin Tang, Jianhua Zhang, Vinod Ravi, Keila E. Torres, Bhavisha Khatri, Dina Halai, Ioannis Roxanis, Daniel Baumhoer, Roberto Tirabosco, Maria Fernanda Amary, Chris Boshoff, Ultan McDermott, Matilda Katan, Michael R. Stratton, P. Andrew Futreal, Adrienne M. Flanagan, Adrian L. Harris, Peter J. Campbell - Nature Genetics 2014 cited by 315

  10. Kaposi's Sarcoma Herpesvirus MicroRNAs Induce Metabolic Transformation of Infected Cells

    Authors: , , , - PLoS Pathogens 2014 cited by 119

  11. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator

    Authors: , , , , , , , - Nature Cell Biology 2010 cited by 337

  12. High incidence of Kaposi sarcoma–associated herpesvirus–related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease

    Authors: , , , , , , , , , , , , - Blood 2002 cited by 409

  13. Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Gene Expression as Revealed by DNA Arrays

    Authors: , , , - Journal of Virology 2001 cited by 378

  14. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming

    Authors: , , , , , , , , , , , - Genes & Development 2010 cited by 167

  15. Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 705

  16. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma

    Authors: , , , , , , , , - Blood 2000 cited by 654

  17. Aids-related malignancies

    Authors: , - Nature reviews. Cancer 2002 cited by 433

  18. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors

    Authors: , , , , , , , , , , , , , , , , , , , - Genome Medicine 2013 cited by 217

  19. The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis

    Authors: , , , , , , , - Blood 2012 cited by 190

  20. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA

    Authors: , , , , - Blood 2004 cited by 185

  21. KSHV-Initiated Notch Activation Leads to Membrane-Type-1 Matrix Metalloproteinase-Dependent Lymphatic Endothelial-to-Mesenchymal Transition

    Authors: , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2011 cited by 140

  22. KSHV LANA inhibits TGF-β signaling through epigenetic silencing of the TGF-β type II receptor

    Authors: , , , , , , - Blood 2008 cited by 125

  23. Crystal Structure of a vFlip-IKKγ Complex: Insights into Viral Activation of the IKK Signalosome

    Authors: , , , , , , , - Molecular Cell 2008 cited by 124

  24. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 89